BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.
Latest borrow fee for BeiGene
(BGNE) shares on Interactive Brokers: 0.2500% (annualized)
Shares available to borrow: 450000
The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock. Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.
BeiGene
(BGNE) - cost to borrow in the last 7 days chart
BeiGene
(BGNE) - number of shares available to borrow in the last 7 days
BeiGene
(BGNE) - cost to borrow from 2024 to 2023
BeiGene
(BGNE) - number of shares available to borrow from 2024 to 2023
Cost to borrow for shares of similar companies or competitors